Midlife blood pressure change and left ventricular mass and remodelling in older age in the 1946 British birth cohort study

European Heart Journal

Volumn 35, Issue 46, 2014, Pages 3287-3295

  Ghosh, Arjun K ^a,b   Hardy, Rebecca J ^b   Francis, Darrel P ^a   Chaturvedi, Nishi ^b   Pellerin, Denis ^b   Deanfield, John ^b   Kuh, Diana ^b   Mayet, Jamil ^a   Hughes, Alun D ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Echocardiography; Left ventricular hypertrophy; Left ventricular mass

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LEFT VENTRICLE REMODELLING; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MIDLIFE BLOOD PRESSURE; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; COMPLICATION; HEART VENTRICLE REMODELING; HYPERTROPHY, LEFT VENTRICULAR; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR REMODELING;

EID: 84921636851     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu389     Document Type: Article

References (37)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-Analysis of individual data forone million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
3. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 996-1004.
4. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM. Lifetime risks of cardiovascular disease. N Engl J Med 2012; 366: 321-329.
5. Allen N, Berry JD, Ning H, Van Horn L, Dyer A, Lloyd-Jones DM. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation 2012; 125: 37-44.
6. Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol 2011; 58: 2396-2403.
7. Vasan RS, Massaro JM, Wilson PWF, Seshadri S, Wolf PA, Levy D, DAgostino RB. Antecedent blood pressure and risk of cardiovascular disease: the Framingham heart study. Circulation 2002; 105: 48-53.
8. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-Analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115: 41-46.
9. Wadsworth M, Kuh D, Richards M, Hardy R. Cohort profile: the 1946 National Birth Cohort (MRC National Survey of Health and Development). Int J Epidemiol 2006; 35: 49-54.
10. Stang A. Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 2006; 164: 85-94.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiographys Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
12. Chirinos JA, Segers P, De Buyzere ML, Kronmal RA, Raja MW, De Bacquer D, Claessens T, Gillebert TC, St John-Sutton M, Rietzschel ER. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 2010; 56: 91-98.
13. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
14. Kuh D, Pierce M, Adams J, Deanfield J, Ekelund U, Friberg P, Ghosh AK, Harwood N, Hughes A, Macfarlane PW, Mishra G, Pellerin D, Wong A, Stephen AM, Richards M, Hardy R. Cohort profile: updating the cohort profile for theMRCNational Survey of Health and Development: a new clinic-based data collection for ageing research. Int J Epidemiol 2011; 40: e1-e9.
15. Mishra G, Nitsch D, Black S, De SB, Kuh D, Hardy R. A structured approach to modelling the effectsof binary exposure variablesover the life course. Int J Epidemiol 2009; 38: 528-537.
16. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 1995; 91: 2400-2406.
17. Toprak A, Wang H, Chen W, Paul T, Srinivasan S, Berenson G. Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study). Am J Cardiol 2008; 101: 1621-1625.
18. Dekkers C, Treiber FA, Kapuku G, Van Den Oord EJ, Snieder H. Growth of left ventricular mass in African American and EuropeanAmerican youth. Hypertension 2002; 39: 943-951.
19. Ridderstrale W, Saluveer O, Johansson MC, Bergbrant A, Jern S, Hrafnkelsdottir TJ. Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men. J Intern Med 2010; 267: 295-304.
20. Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjornerheim R, Kjeldsen SE. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 2006; 24: 905-913.
21. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346-2351.
22. Lieb W, Xanthakis V, Sullivan LM, Aragam J, Pencina MJ, Larson MG, Benjamin EJ, Vasan RS. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short-And long-Term change in the Framingham offspring study. Circulation 2009; 119: 3085-3092.
23. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LVmass assessed by echocardiography andCMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 2012; 5: 837-848.
24. Armstrong AC, Jacobs DR Jr, Gidding SS, Colangelo LA, Gjesdal O, Lewis CE, Bibbins-Domingo K, Sidney S, Schreiner PJ, Williams OD, Goff DC Jr, Liu K, Lima JA. Framingham score and LV mass predict events in young adults: CARDIA study. Int J Cardiol 2014; 172: 350-355.
25. Wills AK, Lawlor DA, Matthews FE, Sayer AA, Bakra E, Ben-Shlomo Y, Benzeval M, Brunner E, Cooper R, Kivimaki M, Kuh D, Muniz-Terrera G, Hardy R. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med 2011; 8: e1000440.
26. Joas E, Backman K, Gustafson D, Ostling S, Waern M, Guo X, Skoog I. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 2012; 59: 796-801.
27. Launer LJ, Hughes T, Yu B, Masaki K, Petrovitch H, Ross GW, White LR. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension 2010; 55: 1352-1359.
28. Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension 2002; 39: 744-749.
29. Frohlich ED. Left ventricular hypertrophy: a factor of risk: mass is reversible, but is the risk? J Am Coll Cardiol 2004; 43: 2216-2218.
30. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004; 55: 373-394.
31. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 2010; 106: 1675-1680.
32. Mancia G, Laurent S, gabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158.
33. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
34. Skov K, Julius S, Nesbitt S, Mulvany MJ. Can hypertension be prevented? The Danish Hypertension Prevention Project and the Trial of Prevention of Hypertension studies. Curr Opin Cardiol 2002; 17: 380-384.
35. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685-1697.
36. Pierce MB, Silverwood RJ, Nitsch D, Adams JE, Stephen AM, Nip W, Macfarlane P, Wong A, Richards M, Hardy R, Kuh D, Scientific N, Data Collection T. Clinical disorders in a post war British cohort reaching retirement: evidence from the First National Birth Cohort study. PLoS ONE 2012; 7: e44857.
37. Zureik M, Bonithon-Kopp C, Diebold B, Ducimetiere P, Guize L. Combined effects of blood pressure and body mass index on left ventricular structure in middle-Aged males: cross-sectional and 2-year longitudinal results. J Hypertens 1995; 13: 979-985.